Tactile Systems Technology (TCMD) Stock Price, News & Analysis

Company Overview

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Key Stats

• Today's Range: $10.09 to $10.67
• 50-Day Range: $9.42 to $10.48
• 52-Week Range: $8.61 to $21.10
• Volume: 140,477 shs
• Average Volume: 278,124 shs
• Market Capitalization: $245.94 million
• P/E Ratio: 16.00
• Dividend Yield: N/A
• Price Target: $16.00
• Consensus Rating: Hold

Tactile Systems Technology Stock Analysis - MarketRank™

Tactile Systems Technology scored higher than 71% of companies evaluated by MarketBeat, and ranked 316th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Tactile Systems Technology has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Tactile Systems Technology has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 20.00%

Earnings Growth

Earnings for Tactile Systems Technology are expected to grow by 20.00% in the coming year, from $0.70 to $0.84 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tactile Systems Technology is 16.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.79.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tactile Systems Technology is 16.06, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.07.

Price to Book Value per Share Ratio

Tactile Systems Technology has a P/B Ratio of 1.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.63% of the float of Tactile Systems Technology has been sold short.

Short Interest Ratio / Days to Cover

Tactile Systems Technology has a short interest ratio ("days to cover") of 8.

Change versus previous month

Short interest in Tactile Systems Technology has recently decreased by 0.41%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tactile Systems Technology does not currently pay a dividend.

Dividend Growth

Tactile Systems Technology does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

10.63% of the float of Tactile Systems Technology has been sold short.

Short Interest Ratio / Days to Cover

Tactile Systems Technology has a short interest ratio ("days to cover") of 8.

Change versus previous month

Short interest in Tactile Systems Technology has recently decreased by 0.41%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.93

News Sentiment

Tactile Systems Technology has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.06 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Tactile Systems Technology this week, compared to 3 articles on an average week.

Search Interest

Only 4 people have searched for TCMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

7 people have added Tactile Systems Technology to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Tactile Systems Technology insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $60,946.00 in company stock.

Percentage Held by Insiders

Only 2.50% of the stock of Tactile Systems Technology is held by insiders.

Percentage Held by Institutions

83.43% of the stock of Tactile Systems Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

TCMD Stock Analysis - Frequently Asked Questions

How have TCMD shares performed this year?

Tactile Systems Technology's stock was trading at $17.13 at the start of the year. Since then, TCMD shares have decreased by 38.2% and is now trading at $10.59.

How were Tactile Systems Technology's earnings last quarter?

Tactile Systems Technology, Inc. (NASDAQ:TCMD) released its earnings results on Monday, May, 5th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.06. The business earned $61.27 million during the quarter, compared to analysts' expectations of $63.48 million. Tactile Systems Technology had a net margin of 5.52% and a trailing twelve-month return on equity of 8.41%.
Read the conference call transcript.

When did Tactile Systems Technology IPO?

Tactile Systems Technology (TCMD) raised $40 million in an IPO on Thursday, July 28th 2016. The company issued 4,000,000 shares at $10.00 per share. Piper Jaffray, William Blair and Canaccord Genuity acted as the underwriters for the IPO and BTIG was co-manager.

Who are Tactile Systems Technology's major shareholders?

Top institutional shareholders of Tactile Systems Technology include Kopp Family Office LLC (0.58%), Blair William & Co. IL (0.40%), SummerHaven Investment Management LLC (0.29%) and Janney Montgomery Scott LLC (0.11%). Insiders that own company stock include Daniel L Reuvers, Elaine M Birkemeyer, Kristie Burns, Brent Moen and William W Burke.
View institutional ownership trends.

How do I buy shares of Tactile Systems Technology?

Shares of TCMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tactile Systems Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tactile Systems Technology investors own include Chevron (CVX), American Water Works (AWK), Humana (HUM), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR) and Bristol Myers Squibb (BMY).

Company Calendar

• Last Earnings: 5/05/2025
• Today: 7/25/2025
• Next Earnings (Estimated): 8/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:TCMD
• CIK: 1027838
• Web: www.tactilemedical.com
• Phone: (612) 355-5100
• Fax: 866-435-3949
• Employees: 1,037
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Tactile Systems Technology: $16.00
• High Price Target: $18.00
• Low Price Target: $14.00
• Potential Upside/Downside: +53.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.66
• Trailing P/E Ratio: 15.77
• Forward P/E Ratio: 14.85
• P/E Growth: N/A
• Net Income: $16.96 million
• Net Margins: 5.52%
• Pretax Margin: 7.58%
• Return on Equity: 8.41%
• Return on Assets: 6.10%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 4.52
• Quick Ratio: 3.99

Sales & Book Value

• Annual Sales: $293.16 million
• Price / Sales: 0.82
• Cash Flow: $1.07 per share
• Price / Cash Flow: 9.68
• Book Value: $9.03 per share
• Price / Book: 1.15

Miscellaneous

• Outstanding Shares: 23,248,000
• Free Float: 22,667,000
• Market Cap: $241.69 million
• Optionable: Optionable
• Beta: 0.95